However, an understanding of the neurobiology of the syndrome also predicts that executive difficulties should not be the sole characteristic cognitive deficit in FXS: multiple cognitive processes may be affected by the changes in neurocomputational properties associated with FMR1 silencing and its related cascade of molecular events. The gene discussed is FMR1; the disease is fragile X syndrome.